A detailed history of Jpmorgan Chase & CO transactions in Cutera Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 584 shares of CUTR stock, worth $192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
584
Previous 582 0.34%
Holding current value
$192
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.66 - $1.67 $1 - $3
2 Added 0.34%
584 $0
Q2 2024

Aug 12, 2024

SELL
$1.38 - $2.86 $24,002 - $49,743
-17,393 Reduced 96.76%
582 $0
Q1 2024

May 10, 2024

BUY
$1.39 - $4.79 $7,977 - $27,489
5,739 Added 46.9%
17,975 $26,000
Q4 2023

Feb 12, 2024

SELL
$1.68 - $5.33 $12,872 - $40,838
-7,662 Reduced 38.51%
12,236 $43,000
Q3 2023

Nov 14, 2023

BUY
$6.02 - $20.05 $40,520 - $134,956
6,731 Added 51.12%
19,898 $119,000
Q2 2023

Aug 11, 2023

SELL
$14.14 - $27.07 $539,907 - $1.03 Million
-38,183 Reduced 74.36%
13,167 $199,000
Q1 2023

May 18, 2023

BUY
$23.52 - $42.73 $299,009 - $543,226
12,713 Added 32.9%
51,350 $1.21 Million
Q1 2023

May 11, 2023

SELL
$23.52 - $42.73 $251,264 - $456,484
-10,683 Reduced 21.66%
38,637 $912,000
Q4 2022

Feb 13, 2023

SELL
$39.63 - $51.65 $729,033 - $950,153
-18,396 Reduced 27.17%
49,320 $2.18 Million
Q3 2022

Nov 14, 2022

SELL
$37.04 - $54.04 $3.38 Million - $4.94 Million
-91,322 Reduced 57.42%
67,716 $3.09 Million
Q2 2022

Aug 11, 2022

SELL
$36.55 - $72.31 $377,013 - $745,877
-10,315 Reduced 6.09%
159,038 $5.96 Million
Q1 2022

May 11, 2022

SELL
$32.12 - $69.0 $1.62 Million - $3.49 Million
-50,517 Reduced 22.98%
169,353 $11.7 Million
Q4 2021

Feb 10, 2022

BUY
$33.71 - $46.72 $525,909 - $728,878
15,601 Added 7.64%
219,870 $9.09 Million
Q3 2021

Nov 12, 2021

BUY
$46.02 - $54.04 $9.4 Million - $11 Million
204,269 New
204,269 $9.52 Million

Others Institutions Holding CUTR

About CUTERA INC


  • Ticker CUTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,575,400
  • Market Cap $6.46M
  • Description
  • Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio...
More about CUTR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.